These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 27608668)

  • 1. Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice.
    Sok D; Briney B; Jardine JG; Kulp DW; Menis S; Pauthner M; Wood A; Lee EC; Le KM; Jones M; Ramos A; Kalyuzhniy O; Adachi Y; Kubitz M; MacPherson S; Bradley A; Friedrich GA; Schief WR; Burton DR
    Science; 2016 Sep; 353(6307):1557-1560. PubMed ID: 27608668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen.
    Jardine JG; Kulp DW; Havenar-Daughton C; Sarkar A; Briney B; Sok D; Sesterhenn F; Ereño-Orbea J; Kalyuzhniy O; Deresa I; Hu X; Spencer S; Jones M; Georgeson E; Adachi Y; Kubitz M; deCamp AC; Julien JP; Wilson IA; Burton DR; Crotty S; Schief WR
    Science; 2016 Mar; 351(6280):1458-63. PubMed ID: 27013733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models.
    Huang D; Abbott RK; Havenar-Daughton C; Skog PD; Al-Kolla R; Groschel B; Blane TR; Menis S; Tran JT; Thinnes TC; Volpi SA; Liguori A; Schiffner T; Villegas SM; Kalyuzhniy O; Pintea M; Voss JE; Phelps N; Tingle R; Rodriguez AR; Martin G; Kupryianov S; deCamp A; Schief WR; Nemazee D; Crotty S
    Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22920-22931. PubMed ID: 32873644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen.
    Jardine JG; Ota T; Sok D; Pauthner M; Kulp DW; Kalyuzhniy O; Skog PD; Thinnes TC; Bhullar D; Briney B; Menis S; Jones M; Kubitz M; Spencer S; Adachi Y; Burton DR; Schief WR; Nemazee D
    Science; 2015 Jul; 349(6244):156-61. PubMed ID: 26089355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies.
    Duan H; Chen X; Boyington JC; Cheng C; Zhang Y; Jafari AJ; Stephens T; Tsybovsky Y; Kalyuzhniy O; Zhao P; Menis S; Nason MC; Normandin E; Mukhamedova M; DeKosky BJ; Wells L; Schief WR; Tian M; Alt FW; Kwong PD; Mascola JR
    Immunity; 2018 Aug; 49(2):301-311.e5. PubMed ID: 30076101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized mice.
    Cottrell CA; Hu X; Lee JH; Skog P; Luo S; Flynn CT; McKenney KR; Hurtado J; Kalyuzhniy O; Liguori A; Willis JR; Landais E; Raemisch S; Chen X; Baboo S; Himansu S; Diedrich JK; Duan H; Cheng C; Schiffner T; Bader DLV; Kulp DW; Tingle R; Georgeson E; Eskandarzadeh S; Alavi N; Lu D; Sincomb T; Kubitz M; Mullen TM; Yates JR; Paulson JC; Mascola JR; Alt FW; Briney B; Sok D; Schief WR
    Sci Transl Med; 2024 May; 16(748):eadn0223. PubMed ID: 38753806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 VRC01 Germline-Targeting Immunogens Select Distinct Epitope-Specific B Cell Receptors.
    Lin YR; Parks KR; Weidle C; Naidu AS; Khechaduri A; Riker AO; Takushi B; Chun JH; Borst AJ; Veesler D; Stuart A; Agrawal P; Gray M; Pancera M; Huang PS; Stamatatos L
    Immunity; 2020 Oct; 53(4):840-851.e6. PubMed ID: 33053332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into Nanoparticles.
    Melo M; Porter E; Zhang Y; Silva M; Li N; Dobosh B; Liguori A; Skog P; Landais E; Menis S; Sok D; Nemazee D; Schief WR; Weiss R; Irvine DJ
    Mol Ther; 2019 Dec; 27(12):2080-2090. PubMed ID: 31515132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires.
    Tian M; Cheng C; Chen X; Duan H; Cheng HL; Dao M; Sheng Z; Kimble M; Wang L; Lin S; Schmidt SD; Du Z; Joyce MG; Chen Y; DeKosky BJ; Chen Y; Normandin E; Cantor E; Chen RE; Doria-Rose NA; Zhang Y; Shi W; Kong WP; Choe M; Henry AR; Laboune F; Georgiev IS; Huang PY; Jain S; McGuire AT; Georgeson E; Menis S; Douek DC; Schief WR; Stamatatos L; Kwong PD; Shapiro L; Haynes BF; Mascola JR; Alt FW
    Cell; 2016 Sep; 166(6):1471-1484.e18. PubMed ID: 27610571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting broadly neutralizing antibody precursors: a naïve approach to vaccine design.
    McGuire AT
    Curr Opin HIV AIDS; 2019 Jul; 14(4):294-301. PubMed ID: 30946041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mRNA-LNP prime boost evolves precursors toward VRC01-like broadly neutralizing antibodies in preclinical humanized mouse models.
    Wang X; Cottrell CA; Hu X; Ray R; Bottermann M; Villavicencio PM; Yan Y; Xie Z; Warner JE; Ellis-Pugh JR; Kalyuzhniy O; Liguori A; Willis JR; Menis S; Rämisch S; Eskandarzadeh S; Kubitz M; Tingle R; Phelps N; Groschel B; Himansu S; Carfi A; Kirsch KH; Weldon SR; Nair U; Schief WR; Batista FD
    Sci Immunol; 2024 May; 9(95):eadn0622. PubMed ID: 38753808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination induces HIV broadly neutralizing antibody precursors in humans.
    Leggat DJ; Cohen KW; Willis JR; Fulp WJ; deCamp AC; Kalyuzhniy O; Cottrell CA; Menis S; Finak G; Ballweber-Fleming L; Srikanth A; Plyler JR; Schiffner T; Liguori A; Rahaman F; Lombardo A; Philiponis V; Whaley RE; Seese A; Brand J; Ruppel AM; Hoyland W; Yates NL; Williams LD; Greene K; Gao H; Mahoney CR; Corcoran MM; Cagigi A; Taylor A; Brown DM; Ambrozak DR; Sincomb T; Hu X; Tingle R; Georgeson E; Eskandarzadeh S; Alavi N; Lu D; Mullen TM; Kubitz M; Groschel B; Maenza J; Kolokythas O; Khati N; Bethony J; Crotty S; Roederer M; Karlsson Hedestam GB; Tomaras GD; Montefiori D; Diemert D; Koup RA; Laufer DS; McElrath MJ; McDermott AB; Schief WR
    Science; 2022 Dec; 378(6623):eadd6502. PubMed ID: 36454825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice.
    McGuire AT; Gray MD; Dosenovic P; Gitlin AD; Freund NT; Petersen J; Correnti C; Johnsen W; Kegel R; Stuart AB; Glenn J; Seaman MS; Schief WR; Strong RK; Nussenzweig MC; Stamatatos L
    Nat Commun; 2016 Feb; 7():10618. PubMed ID: 26907590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen.
    Havenar-Daughton C; Sarkar A; Kulp DW; Toy L; Hu X; Deresa I; Kalyuzhniy O; Kaushik K; Upadhyay AA; Menis S; Landais E; Cao L; Diedrich JK; Kumar S; Schiffner T; Reiss SM; Seumois G; Yates JR; Paulson JC; Bosinger SE; Wilson IA; Schief WR; Crotty S
    Sci Transl Med; 2018 Jul; 10(448):. PubMed ID: 29973404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humanized V(D)J-rearranging and TdT-expressing mouse vaccine models with physiological HIV-1 broadly neutralizing antibody precursors.
    Luo S; Jing C; Ye AY; Kratochvil S; Cottrell CA; Koo JH; Chapdelaine Williams A; Francisco LV; Batra H; Lamperti E; Kalyuzhniy O; Zhang Y; Barbieri A; Manis JP; Haynes BF; Schief WR; Batista FD; Tian M; Alt FW
    Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2217883120. PubMed ID: 36574685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodies.
    Seydoux E; Wan YH; Feng J; Wall A; Aljedani S; Homad LJ; MacCamy AJ; Weidle C; Gray MD; Brumage L; Taylor JJ; Pancera M; Stamatatos L; McGuire AT
    Cell Rep; 2021 May; 35(5):109084. PubMed ID: 33951425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice.
    Escolano A; Steichen JM; Dosenovic P; Kulp DW; Golijanin J; Sok D; Freund NT; Gitlin AD; Oliveira T; Araki T; Lowe S; Chen ST; Heinemann J; Yao KH; Georgeson E; Saye-Francisco KL; Gazumyan A; Adachi Y; Kubitz M; Burton DR; Schief WR; Nussenzweig MC
    Cell; 2016 Sep; 166(6):1445-1458.e12. PubMed ID: 27610569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination induces broadly neutralizing antibody precursors to HIV gp41.
    Schiffner T; Phung I; Ray R; Irimia A; Tian M; Swanson O; Lee JH; Lee CD; Marina-Zárate E; Cho SY; Huang J; Ozorowski G; Skog PD; Serra AM; Rantalainen K; Allen JD; Baboo S; Rodriguez OL; Himansu S; Zhou J; Hurtado J; Flynn CT; McKenney K; Havenar-Daughton C; Saha S; Shields K; Schultze S; Smith ML; Liang CH; Toy L; Pecetta S; Lin YC; Willis JR; Sesterhenn F; Kulp DW; Hu X; Cottrell CA; Zhou X; Ruiz J; Wang X; Nair U; Kirsch KH; Cheng HL; Davis J; Kalyuzhniy O; Liguori A; Diedrich JK; Ngo JT; Lewis V; Phelps N; Tingle RD; Spencer S; Georgeson E; Adachi Y; Kubitz M; Eskandarzadeh S; Elsliger MA; Amara RR; Landais E; Briney B; Burton DR; Carnathan DG; Silvestri G; Watson CT; Yates JR; Paulson JC; Crispin M; Grigoryan G; Ward AB; Sok D; Alt FW; Wilson IA; Batista FD; Crotty S; Schief WR
    Nat Immunol; 2024 Jun; 25(6):1073-1082. PubMed ID: 38816615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies.
    Briney B; Sok D; Jardine JG; Kulp DW; Skog P; Menis S; Jacak R; Kalyuzhniy O; de Val N; Sesterhenn F; Le KM; Ramos A; Jones M; Saye-Francisco KL; Blane TR; Spencer S; Georgeson E; Hu X; Ozorowski G; Adachi Y; Kubitz M; Sarkar A; Wilson IA; Ward AB; Nemazee D; Burton DR; Schief WR
    Cell; 2016 Sep; 166(6):1459-1470.e11. PubMed ID: 27610570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens.
    Abbott RK; Lee JH; Menis S; Skog P; Rossi M; Ota T; Kulp DW; Bhullar D; Kalyuzhniy O; Havenar-Daughton C; Schief WR; Nemazee D; Crotty S
    Immunity; 2018 Jan; 48(1):133-146.e6. PubMed ID: 29287996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.